Vanguard Health Care ETF

VHT

Market cap $16.5B

Expected increased capital spending and the implementation of artificial intelligence (AI) are structural tailwinds for healthcare stocks today. Spending is expected to be 20% of GDP by 2032.

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

Many portfolios are still very heavy in tech and growth stocks. It's time to revisit asset allocations.

Healthcare spending doesn't stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT), a pure-play sector fund that has quietly compounded wealth for long-term investors while offering insulation from economic cycles that most equity sectors can't match.

Are stagflation risks returning as oil-driven inflation rises amid Middle East tensions? Here's how ETFs can help defend portfolios.

With U.S. budget deficits and already elevated debt, the ongoing Middle East war could worsen the fiscal outlook, making defensive ETF strategies worth considering for stability.

Oil above $110 amid Middle East conflict is rattling markets. Here are ETF strategies -- from dividends and defensives to commodities -- that could help navigate the volatility.

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Vanguard Health Care ETF (VHT) is a passively managed exchange traded fund launched on January 26, 2004.

The broader market is sending a clear signal as speculative assets like cryptocurrencies have taken a dive.

From "software-mageddon" to rising AI capex pressuring Big Tech, diversification via defensive and global ETFs gains focus.